Trials / Unknown
UnknownNCT03071172
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
Clinical Study of Recombinant Human Follitropin for Injection Assisted in Controlled Ovarian Hyperstimulation Assisted IVF-ET
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 252 (estimated)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to evaluate the efficacy and safety of domestic recombinant human follicle stimulating hormone (rhFSH) stimulating ovarian to promote follicular development before assisted reproductive technology, which was non-inferiority than that of the imported rhFSH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triptorelin for Injection | Drugs for IVF-ET (in vitro fertilization and embryo transfer). |
| DRUG | Recombinant Human Choriogonadotropin alfa Solution for Injection | Drugs for IVF-ET (in vitro fertilization and embryo transfer). |
| DRUG | Progesterone Soft Capsules | Drugs for IVF-ET (in vitro fertilization and embryo transfer). |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2017-12-01
- Completion
- 2018-05-01
- First posted
- 2017-03-06
- Last updated
- 2017-03-06
Locations
7 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03071172. Inclusion in this directory is not an endorsement.